Healthcare -
Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
RARE - NET INCOME
Net Income RARE - Ultragenyx Pharmaceutical Inc.
-607 M
LAST VALUE
-15.59%
2 YEAR CAGR
-25.15%
5 YEAR CAGR
-32.98%
10 YEAR CAGR